Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.43 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | CETP | P11597 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29573871 | 0.95 | LMNA (0.46) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL16897952 | 0.92 | LMNA (0.50) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL535803 | 0.86 | LMNA (0.50) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL1425231 | 0.85 | LMNA (0.52) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| Valeric Acid SCHEMBL29796187 | 0.80 | ALDH1A1 (0.58) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL28494764 | 0.77 | LMNA (0.57) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL28254695 | 0.77 | LMNA (0.52) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL535804 | 0.76 | ALDH1A1 (0.49) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 | |
| SCHEMBL15927544 | 0.76 | LMNA (0.46) | LMNAALDH1A1SMN1; SMN2KMT2AKDM4E | |
| Butyric Acid SCHEMBL15845048 | 0.73 | ALDH1A1 (0.61) | LMNAEHMT2EHMT1APOBEC3GALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12458705-B2 | Antibody-oligonucleotide conjugates | ANGIEX, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| CN-117642633-A | Method and system for single cell protein analysis | 德克萨斯大学系统董事会 | 2024-03-01 | — | — | CN | disclosed |
| WO-2024041315-A1 | NOVEL ANTI-LILRB2 ANTIBODIES AND USES THEREOF | ANTENGENE (HANGZHOU) BIOLOGICS CO., LTD. (CN) | 2024-02-29 | — | — | WO | disclosed |
| WO-2023236891-A1 | NOVEL ANTI-LILRB4 ANTIBODIES AND USES THEREOF | ANTENGENE (HANGZHOU) BIOLOGICS CO., LTD. (CN) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023227062-A1 | NOVEL ANTI-GPRC5D ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND GPRC5D AND CD3, AND USES THEREOF | ANTENGENE (HANGZHOU) BIOLOGICS CO., LTD. (CN) | 2023-11-30 | — | — | WO | disclosed |
| WO-2023169419-A1 | NOVEL ANTI-CD3 ANTIBODIES AND USES THEREOF | ANTENGENE (HANGZHOU) BIOLOGICS CO., LTD. (CN) | 2023-09-14 | — | — | WO | disclosed |
| EP-4217396-A1 | NOVEL ANTI-CLAUDIN18 ANTIBODIES | Elpiscience (Suzhou) Biopharma, Ltd. (CN) | 2023-08-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12458705-B2 | Antibody-oligonucleotide conjugates | TM9SF4, TMSB4X, IGSF11 | LMNA 2745/4885EHMT2 2945/4885EHMT1 3414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.